BHARAT PARENTERALS
|
BHARAT PARENTERALS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -11.88 | -18.32 | 24.94 | 28.40 | 36.46 |
| CEPS(Rs) | 10.08 | -12.12 | 33.57 | 37.40 | 47.57 |
| DPS(Rs) | 1.00 | 1.00 | 1.00 | 0.75 | - |
| Book NAV/Share(Rs) | 467.55 | 479.79 | 338.96 | 315.63 | 287.16 |
| Tax Rate(%) | -27.46 | -28.64 | 43.84 | 33.26 | 25.34 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 4.57 | 0.79 | 10.32 | 9.17 | 11.58 |
| EBIT Margin(%) | -2.57 | -6.15 | 8.68 | 11.99 | 12.11 |
| Pre Tax Margin(%) | -6.19 | -9.95 | 7.14 | 10.80 | 11.57 |
| PAT Margin (%) | -7.89 | -12.80 | 4.01 | 7.21 | 8.64 |
| Cash Profit Margin (%) | 2.01 | -2.45 | 7.45 | 9.91 | 11.40 |
| Performance Ratios | |||||
| ROA(%) | -4.28 | -7.52 | 2.46 | 5.45 | 9.80 |
| ROE(%) | -8.36 | -16.55 | 5.54 | 9.03 | 13.46 |
| ROCE(%) | -1.82 | -4.85 | 7.74 | 12.57 | 17.18 |
| Asset Turnover(x) | 0.54 | 0.59 | 0.61 | 0.76 | 1.13 |
| Sales/Fixed Asset(x) | 1.02 | 1.18 | 1.56 | 2.85 | 3.35 |
| Working Capital/Sales(x) | 2.27 | 2.56 | 3.63 | 3.38 | 2.36 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.98 | 0.85 | 0.64 | 0.35 | 0.30 |
| Receivable days | 170.08 | 167.50 | 176.78 | 155.57 | 106.98 |
| Inventory Days | 82.65 | 71.36 | 69.16 | 49.06 | 32.72 |
| Payable days | 131.69 | 122.16 | 127.69 | 99.70 | 66.97 |
| Valuation Parameters | |||||
| PER(x) | - | - | 44.99 | 11.83 | 9.36 |
| PCE(x) | 89.34 | -81.47 | 33.43 | 8.98 | 7.18 |
| Price/Book(x) | 1.93 | 2.06 | 3.31 | 1.06 | 1.19 |
| Yield(%) | 0.11 | 0.10 | 0.09 | 0.22 | - |
| EV/Net Sales(x) | 2.18 | 2.36 | 3.05 | 1.07 | 0.99 |
| EV/Core EBITDA(x) | 29.75 | 56.08 | 25.07 | 7.30 | 5.86 |
| EV/EBIT(x) | -84.90 | -38.24 | 35.01 | 8.94 | 7.20 |
| EV/CE(x) | 1.61 | 1.57 | 2.24 | 1.01 | 0.93 |
| M Cap / Sales | 1.80 | 2.00 | 2.50 | 0.89 | 0.93 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 1.48 | 30.31 | 19.83 | 2.81 | 3.60 |
| Core EBITDA Growth(%) | 77.10 | -54.91 | -0.83 | -10.65 | 5.67 |
| EBIT Growth(%) | 57.67 | -192.36 | -13.03 | -10.42 | 4.63 |
| PAT Growth(%) | 37.48 | -515.39 | -33.09 | -24.49 | 2.44 |
| EPS Growth(%) | 35.15 | -173.44 | -12.16 | -22.11 | 2.45 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.45 | 0.54 | 0.80 | 0.27 | 0.11 |
| Current Ratio(x) | 1.97 | 1.58 | 1.38 | 1.54 | 3.46 |
| Quick Ratio(x) | 1.43 | 1.27 | 1.06 | 1.22 | 2.96 |
| Interest Cover(x) | -0.71 | -1.62 | 5.66 | 10.07 | 22.35 |
| Total Debt/Mcap(x) | 0.24 | 0.26 | 0.24 | 0.26 | 0.09 |
Compare Financial Ratios of peers of BHARAT PARENTERALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BHARAT PARENTERALS | ₹1,314.2 Cr | 10.9% | 23.9% | 50% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -3.2% | -7.8% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 1% | 0.9% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,822.0 Cr | -1.8% | -4.8% | 32.2% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -3.1% | -6.5% | -12.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -1.7% | 3.1% | -3.5% | Stock Analytics | |
BHARAT PARENTERALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BHARAT PARENTERALS | 10.9% |
23.9% |
50% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses
